Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis

Conditions:   COVID-19 Respiratory Infection;   Pulmonary Tuberculoses Intervention:   Sponsor:   Tuberculosis Research Centre, India Not yet recruiting

Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials